Cargando…

Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial Design

IMPORTANCE: Clinical trials are testing vaccines that target human papillomavirus 16 (HPV-16) oncoproteins for the treatment of cervical cancer regardless of the HPV type of the tumor. For patients with HPV-18–positive cancers, this strategy relies on cross-reactivity of HPV-16–reactive T cells agai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helman, Sarah R., Stevanović, Sanja, Campbell, Tracy E., Kwong, Mei Li M., Doran, Stacey L., Faquin, William C., Hinrichs, Christian S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324313/ https://www.ncbi.nlm.nih.gov/pubmed/30646017 http://dx.doi.org/10.1001/jamanetworkopen.2018.0706

Ejemplares similares

T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
por: Doran, Stacey L., et al.
Publicado: (2019)

Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
por: Hinrichs, Christian S, et al.
Publicado: (2013)

Adoptively transferred tumor-infiltrating T cells target somatic cancer mutations in a human papillomavirus+ cancer patient with complete tumor regression
por: Stevanović, Sanja, et al.
Publicado: (2015)

Association of Maternal Cervical Disease With Human Papillomavirus Vaccination Among Offspring
por: Worsham, Christopher M., et al.
Publicado: (2021)

Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination
por: Grimes, David Robert, et al.
Publicado: (2021)

Test Performance of Cervical Cytology Among Adults With vs Without Human Papillomavirus Vaccination
por: Teoh, Deanna, et al.
Publicado: (2022)

Use of Virus Genotypes in Machine Learning Diagnostic Prediction Models for Cervical Cancer in Women With High-Risk Human Papillomavirus Infection
por: Xiao, Ting, et al.
Publicado: (2023)

The role of multiple high-risk human papillomavirus infections for cervical biopsies and findings in colposcopic procedures
por: Akış, Serkan, et al.
Publicado: (2023)

Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening
por: Meenan, Richard T., et al.
Publicado: (2023)

Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1
por: Marcinkowski, Bridget, et al.
Publicado: (2019)

Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial
por: Zhang, Junji, et al.
Publicado: (2020)

Incidence and Types of Human Papillomavirus Infections in Adolescent Girls and Young Women Immunized With the Human Papillomavirus Vaccine
por: Schlecht, Nicolas F., et al.
Publicado: (2021)

Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
por: Lee, Sung-Jong, et al.
Publicado: (2016)

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program
por: Wentzensen, Nicolas, et al.
Publicado: (2019)

Deregulation of the miRNAs Expression in Cervical Cancer: Human Papillomavirus Implications
por: Gómez-Gómez, Yazmín, et al.
Publicado: (2013)

Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy
por: Petrizzo, Annacarmen, et al.
Publicado: (2021)

Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial
por: Winer, Rachel L., et al.
Publicado: (2019)

Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries
por: Eggers, Kai M, et al.
Publicado: (2021)

Prognostic Implication of Human Papillomavirus Types and Species in Cervical Cancer Patients Undergoing Primary Treatment
por: Lau, Yat Ming, et al.
Publicado: (2015)

Human Papillomavirus Awareness by Educational Level and by Race and Ethnicity
por: Stephens, Erica S., et al.
Publicado: (2023)

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
por: Nygård, Mari, et al.
Publicado: (2020)

Distribution of human papillomavirus genotypes in cervical lesions
por: Ma, Li, et al.
Publicado: (2017)

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer
por: Boursnell, M.E.G., et al.
Publicado: (1996)

Human Papillomavirus and Cervical Cancer
por: Unger, Elizabeth R., et al.
Publicado: (2004)

Prevalence of Oral Human Papillomavirus Infection Among Australian Indigenous Adults
por: Jamieson, Lisa M., et al.
Publicado: (2020)

Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health
por: Sammarco, Michela Lucia, et al.
Publicado: (2020)

Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan
por: Onuki, Mamiko, et al.
Publicado: (2020)

Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications
por: Sausen, Daniel G., et al.
Publicado: (2023)

Association of Infection With Human Papillomavirus and Development of End-Stage Kidney Disease in Taiwan
por: Chang, Renin, et al.
Publicado: (2020)

Association Between Human Papillomavirus Infection Among Pregnant Women and Preterm Birth
por: Niyibizi, Joseph, et al.
Publicado: (2021)

Assessment of Human Papillomavirus Vaccination in Primary Care Among Swiss University Students
por: Jäger, Levy, et al.
Publicado: (2023)

RNA sequencing-based screen for reactivation of silenced alleles of autosomal genes
por: Gupta, Saumya, et al.
Publicado: (2021)

Involvement of Human Papillomaviruses in Cervical Cancer
por: Wang, Xuelian, et al.
Publicado: (2018)

Human Papillomavirus Related Multiphenotypic Sinonasal Carcinoma: Report of a Case with Early and Progressive Metastatic Disease
por: Rodarte, Alejandro I., et al.
Publicado: (2019)

Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus–Associated Cancers
por: Suk, Ryan, et al.
Publicado: (2018)

Use of Deep Learning to Analyze Social Media Discussions About the Human Papillomavirus Vaccine
por: Du, Jingcheng, et al.
Publicado: (2020)

Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States
por: Sonawane, Kalyani, et al.
Publicado: (2021)

Association Between Human Papillomavirus Vaccination and Primary Ovarian Insufficiency in a Nationwide Cohort
por: Hviid, Anders, et al.
Publicado: (2021)

Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017
por: Liao, Cheng-I., et al.
Publicado: (2022)

Oral Human Papillomavirus Prevalence and Genotyping Among a Healthy Adult Population in the US
por: Giuliano, Anna R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r7er44n9ula17ekmc701elt5jv